Furthermore, it was also found that PKM2 expression in the tumor cells could serve as an independent prognostic factor, which indicates that PKM2 is a potential therapeutic target to improve anti-cancer efficacy of lung cancer patients. Here, PKM is linked to lung carcinoma.